4.7 Article

Desmoplasia of Pancreatic Ductal Adenocarcinoma

Journal

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
Volume 7, Issue 11, Pages S44-S47

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.cgh.2009.07.039

Keywords

-

Funding

  1. NCCIH NIH HHS [P01 AT003960, P01AT003960] Funding Source: Medline
  2. NCI NIH HHS [R01 CA119025, R01CA119025] Funding Source: Medline
  3. NIAAA NIH HHS [P60 AA11999, R03 AA016008, P50 AA011999, R21AA016840] Funding Source: Medline

Ask authors/readers for more resources

Pancreatic ductal adenocarcinoma (PDAC) is the most common form of pancreatic cancer and is characterized by remarkable desmoplasia. The desmoplasia is composed of extracellular matrix (ECM) proteins, myofibroblastic pancreatic stellate cells, and immune cells associated with a multitude of cytokines, growth factors, and ECM metabolizing enzymes. The mechanisms of participation of this complex matrix process in carcinogenesis are only starting to be appreciated. Recent studies showed key roles for stellate cells in the production of ECM proteins as well as cytokines and growth factors that promote the growth of the cancer cells all present in the desmoplastic parts of PDAC. In addition, interactions of ECM proteins and desmoplastic secreted growth factors with the cancer cells of PDAC activate intracellular signals including reactive oxygen species that act to make the cancer cells resistant to dying. These findings suggest that the desmoplasia of PDAC is a key factor in regulating carcinogenesis of PDAC as well as responses to therapies. A better understanding of the biology of desmoplasia in the mechanism of PDAC will likely provide significant opportunities for better treatments for this devastating cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available